FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application to allow Prasco Laboratories to market Fluticasone Propionate Diskus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Propionate Diskus (Fluticasone Propionate)

Snippet

SUPPL AP for FLUTICASONE PROPIONATE DISKUS (FLUTICASONE PROPIONATE)